Sylvester Comprehensive Cancer Center is one of a very limited number of sites in the United States that will provide a newly approved innovative treatment for diffuse large B cell lymphoma — an aggressive form of blood cancer. It takes a patient’s own immune cells (T cells), and uses state-of-the-art genetic engineering to transform them into a supercharged cancer-hunting cellular therapy.
Starting in 2018, Comic Cure, a company that uses the power of laughter to uplift and engage social communities around important causes, will partner with Sylvester Comprehensive Cancer Center to produce quarterly comedy shows that will be broadcast live to all seven Sylvester locations throughout South Florida. “If laughter is the best medicine, then we are the pharmacy,” said Comic Cure co-founder Benjamin Leis.
Many breast cancer patients share similar stories, but there is always something about each patient’s story that is unique. In honor of Breast Cancer Awareness Month, here are the profiles of three women who are long-time patients of radiologist Nilza Kallos, M.D., Sylvester Comprehensive Cancer Center’s director of women’s imaging at The Lennar Foundation Medical Center.
With three children and nine grandchildren spread around the country, Patricia Emard, 64, who retired as assistant director of bus operations for Miami-Dade Transit, enjoys traveling and visiting family members. In fact, in the spring of 2015, she was staying with her daughter, Rachelle, in Washington, D.C., when she discovered a lump in her breast during one of her regular self-examinations.
The Florida Cancer Data System, the State of Florida’s legislatively mandated population-based registry located at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, has received three important distinctions for the quality of its cancer registry data.
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have received a three-year, $1.5 million grant to study a protein known as RAGE — an acronym for Receptor for Advanced Glycation End-products — that may be a link between diabetes and breast cancer.
A University of Miami Miller School of Medicine research team has identified an innovative epigenetic strategy using a single molecule to turn off multiple genes that drive Alzheimer’s disease. The researchers demonstrated that an epigenetic molecule called M344 penetrates the brain, targets the buildup of beta-amyloid peptides associated with Alzheimer’s disease, increases neuroprotective genes and increases memory.
The Miami Dolphins announced the Dolphins Cancer Challenge VII (DCC VII) raised $6,000,157 for innovative cancer research at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, bringing the event’s seven-year total to more than $22.5M.
A Sylvester Comprehensive Cancer Center genetics researcher was honored today with the prestigious “Pioneer Award” and a five-year $5+ million grant from the National Institutes of Health (NIH). The grant will support Ramin Shiekhattar, Ph.D., professor of human genetics at the University of Miami Miller School of Medicine, in pursuing a novel line of research on “Enhancer RNA Therapy.”
By sending non-perishable medical supplies, setting up an international communications network and arranging transport for patients needing urgent care, the University of Miami Miller School of Medicine is mobilizing its resources to help Puerto Rico’s medical community after the devastation of Hurricane Maria.